KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Equity (2016 - 2025)

Historic Return on Equity for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q3 2025 value amounting to 0.21%.

  • Vertex Pharmaceuticals' Return on Equity rose 2400.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.03% for FY2024, which is 2600.0% down from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Return on Equity of 0.21% as of Q3 2025, which was up 2400.0% from 0.22% recorded in Q2 2025.
  • Vertex Pharmaceuticals' Return on Equity's 5-year high stood at 0.31% during Q1 2021, with a 5-year trough of 0.06% in Q1 2025.
  • For the 5-year period, Vertex Pharmaceuticals' Return on Equity averaged around 0.18%, with its median value being 0.22% (2024).
  • The largest annual percentage gain for Vertex Pharmaceuticals' Return on Equity in the last 5 years was 2500bps (2025), contrasted with its biggest fall of -2800bps (2025).
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Return on Equity stood at 0.24% in 2021, then increased by 3bps to 0.25% in 2022, then decreased by -14bps to 0.21% in 2023, then tumbled by -116bps to 0.03% in 2024, then surged by 737bps to 0.21% in 2025.
  • Its Return on Equity was 0.21% in Q3 2025, compared to 0.22% in Q2 2025 and 0.06% in Q1 2025.